ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,905Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 633

$706K Total Retail Price of All Prescriptions

Rank: 24 out of 633

426 Patients Receiving at Least One Drug in Part D
74% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

10% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 470 345 74 1 2
LEVOTHYROXINE SODIUM 444 350 62 2 1
SIMVASTATIN 424 355 66 3 3
ATORVASTATIN CALCIUM 376 287 79 4 9
HYDROCODONE-ACETAMINOPHEN 346 167 72 S3 5 8
METFORMIN HCL 296 201 47 6 10
AMLODIPINE BESYLATE 289 256 47 7 4
CRESTOR 278 189 40 8 27
LISINOPRIL 269 220 47 9 5
HYDROCHLOROTHIAZIDE 239 234* 44 10 14
PIOGLITAZONE HCL 228 189 35 R 11 62
PRAVASTATIN SODIUM 214 195 35 12 21
WARFARIN SODIUM 211 206* 26 13 7
ZETIA 197 192* 23 14 85
ALPRAZOLAM 187 110 32 B 15 32
ALENDRONATE SODIUM 160 155* 21 16 35
FUROSEMIDE 142 121 30 17 6
ZOLPIDEM TARTRATE 142 92 23 17 26
GABAPENTIN 141 129 23 19 16
CLONAZEPAM 140 81 23 B 20 54
POTASSIUM CHLORIDE 140 117 26 20 11
METOPROLOL TARTRATE 140 127 23 20 12
SERTRALINE HCL 130 118 25 23 19
TAMSULOSIN HCL 126 121* 15 24 24
DOXYCYCLINE HYCLATE 114 80 74 25 177
TRIAMTERENE-HCTZ 112 112 21 26 49
LOVASTATIN 100 95* 16 27 70
CLONIDINE HCL 99 83 17 28 65
METOPROLOL SUCCINATE 98 79 15 29 13
DONEPEZIL HCL 98 98 11 29 33
FENOFIBRATE* 96 76 14 31 60
OXYCODONE HCL-ACETAMINOPHEN 93 48 22 S2 32 115
FENOFIBRATE* 91 57 14 33 60
PREDNISONE 88 67 47 34 36
NAMENDA 86 <11 <11 35 34
METHYLPREDNISOLONE 85 55 64 36 184
TRAMADOL HCL 78 56 26 37 15
CARVEDILOL 78 66 12 37 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 49 14 39 31
ADVAIR DISKUS 75 39 18 40 51
MELOXICAM 72 61 29 41 23
LORAZEPAM 71 51 16 B 42 37
DEXAMETHASONE 71 49 54 42 277
CLOPIDOGREL 69 69 12 44 30
CITALOPRAM HBR 68 63* 13 45 20
CELEBREX 67 54 12 46 61
LEVOFLOXACIN 67 42 56 46 83
TRIAMCINOLONE ACETONIDE 65 52 46 48 95
LOSARTAN POTASSIUM 64 41 13 49 17
ATENOLOL 63 58* 13 50 22
SYMBICORT 62 36 13 51 119
BYSTOLIC 60 <11 <11 52 55
NABUMETONE 59 29 12 53 131
NIASPAN 59 <11 <11 53 120
OXYBUTYNIN CHLORIDE 58 44 11 55 93
JANUVIA 58 <11 <11 55 97
PANTOPRAZOLE SODIUM 58 41 13 55 28
SYNTHROID 56 <11 <11 58 64
PROAIR HFA 55 19 22 59 76
FENOFIBRATE* 52 <11 <11 60 60
NEXIUM 51 <11 <11 61 47
POLYETHYLENE GLYCOL 3350 51 31 12 61 29
SPIRIVA 51 <11 <11 61 67
ENALAPRIL MALEATE 50 <11 <11 64 42
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.